Market Overview:
Point-of-care diagnostics (POC) refers to medical testing performed directly at or near the location of patient care, rather than relying on centralized laboratories or hospital settings. These tests are designed to deliver fast, accurate results, enabling healthcare providers to make timely and informed decisions about patient diagnosis and treatment. The key benefit is to allow for immediate decision-making, eliminating the wait for test results or the need for patients to travel to another facility for testing.
The field of point-of-care diagnostics is rapidly evolving, offering significant advancements that make healthcare more efficient and accessible. This innovation is especially important in North America, where both healthcare providers and patients are increasingly turning to POC solutions to streamline the diagnostic process. With growing adoption and continuous advancements, POC diagnostics are revolutionizing healthcare delivery by offering quicker, more reliable results right at the point of care.
Several factors are driving the expansion of the point-of-care diagnostics market in North America. Technological advancements in areas like mobile health integration, artificial intelligence (AI), and digital diagnostics are at the forefront of this transformation. Additionally, the aging population and the rising incidence of chronic diseases are fuelling the demand for more efficient diagnostic solutions. Moreover, the growing trend of home-based testing is contributing to the shift towards point-of-care diagnostics, making it easier for patients to manage their health from the comfort of their homes.
With these rapid innovations, the market for point-of-care diagnostics is well-positioned to meet the needs of both healthcare providers and patients in North America. By providing faster, more reliable diagnostics at the point of care, POC technology is improving healthcare access and efficiency, ultimately leading to better patient outcomes and more effective treatment decisions.
Market Size & Growth Rate:
According to the DataM market research report, the North America point-of-care diagnostics market size is valued at USD 6.7 billion in 2024, it is expected to reach USD 13.2 billion by 2033, with growth at a CAGR of 7.9% over the forecast period 2024-2033.
North America Point-of-Care Diagnostics Market Segmentation
By Product
- Infectious Disease Testing Products
- Blood Glucose Products
- Blood Gas & Electrolyte Products
- Hematology Testing Products
- Urinalysis Products
- Pregnancy and Fertility Testing Products
- Tumor/Cancer Profiling Products
- Drug-of-Abuse Products
- Others
By Technology
- Lateral Flow Assays
- Immunoassays
- Molecular Diagnostics
- Microfluidics
- Others
By Application
- Infectious Diseases
- Hematology
- Cardiology
- Endocrinology
- Oncology
- Drug Testing
- Neurology
- Others
By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care Settings
- Ambulatory Surgery Centers (ASCs)
By Country
- U.S.
- Canada
- Mexico
Recent Developments in the Industry:
- In August 2024, HemoCue unveiled its revitalized brand. This rebranding represents a significant step in the company’s ongoing evolution, underscoring its dedication to addressing the evolving needs of the point-of-care diagnostics sector in a rapidly changing healthcare environment.
- In February 2024, HemoCue partnered with Novo Nordisk to enhance point-of-care diagnostic testing for children with type 1 diabetes in low- and middle-income countries. This collaboration aims to improve access to essential diagnostic tools and care for children living with type 1 diabetes in these regions.
Major Companies:
Major companies involved in the point-of-care diagnostics market include Abbott, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers AG, SEKISUI MEDICAL CO., LTD., BD, BioMérieux, QIAGEN, QuidelOrtho Corporation, and Trinity Biotech Plc, among others.
The Full Report has the following insights:
- The report offers a comprehensive evaluation of the market in terms of market value (US) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2018-2033), and verifiable projections about market size during the forecast period (2024-2033).
- Visualize the composition of the North America point-of-care diagnostics market segmentation by product, technology, application, end-user, and region, highlighting the key commercial assets and players.
- Identify commercial opportunities in the North America point-of-care diagnostics market by analyzing trends and co-development deals.
- The report also covers data insights on various industry forces such as Porter's five forces analysis, supply chain analysis, pricing analysis, and regulatory analysis.
- Excel data sheet with thousands of data points of the North America point-of-care diagnostics market -level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in Excel for the key product of all major market players
- The report will provide access to approximately 61 market data tables, 64 figures, and close to 180 pages.
